The Global and United States Immuno-Oncology Market Report was published by QY Research recently.
Immuno-Oncology Market Analysis and Insights
This report focuses on global and United States Immuno-Oncology market, also covers the segmentation data of other regions in regional level and county level.
Immuno-Oncology market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Immuno-Oncology market will be able to gain the upper hand as they use the report as a powerful resource.
For United States market, this report focuses on the Immuno-Oncology market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Access full Report Description, Table of Figure, Chart, Free sample, etc. please click
Immuno-Oncology Market Segment by Type
Immune Checkpoint Inhibitors
CAR-T Cell Therapy
Immuno-Oncology Market Segment by Application
The report on the Immuno-Oncology market covers the following region analysis:
Middle East & Africa
The report mentions the prominent market player consisting of:
Merck & Co., Inc.
Gilead Sciences Inc.
To study and analyze the global Immuno-Oncology consumption (value & volume) by key regions/countries, type and application, history data from 2017 to 2022, and forecast to 2028.
To understand the structure of Immuno-Oncology market by identifying its various subsegments.
Focuses on the key global Immuno-Oncology manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Immuno-Oncology with respect to individual growth trends, prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges, and risks).
To project the consumption of Immuno-Oncology submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Key Topics Covered
1 Study Coverage
2 Market by Type
3 Market by Application
4 Global Immuno-Oncology Competitor Landscape by Company
5 Global Immuno-Oncology Market Size by Region
5.1 Global Immuno-Oncology Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Immuno-Oncology Market Size in Volume by Region (2017-2028)
5.2.1 Global Immuno-Oncology Sales in Volume by Region: 2017-2022
5.2.2 Global Immuno-Oncology Sales in Volume Forecast by Region (2023-2028)
5.3 Global Immuno-Oncology Market Size in Value by Region (2017-2028)
5.3.1 Global Immuno-Oncology Sales in Value by Region: 2017-2022
5.3.2 Global Immuno-Oncology Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Immuno-Oncology Market Size YoY Growth 2017-2028
6.1.2 North America Immuno-Oncology Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 United States
6.2.1 Asia-Pacific Immuno-Oncology Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Immuno-Oncology Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.5 South Korea
6.2.8 China Taiwan
6.3.1 Europe Immuno-Oncology Market Size YoY Growth 2017-2028
6.3.2 Europe Immuno-Oncology Market Facts & Figures by Country (2017, 2022 & 2028)
6.4 Latin America
6.4.1 Latin America Immuno-Oncology Market Size YoY Growth 2017-2028
6.4.2 Latin America Immuno-Oncology Market Facts & Figures by Country (2017, 2022 & 2028)
6.5 Middle East and Africa
6.5.1 Middle East and Africa Immuno-Oncology Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Immuno-Oncology Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.4 Saudi Arabia
7 Company Profiles
7.1 Bristol-Myers Squibb
7.1.1 Bristol-Myers Squibb Company Details
7.1.2 Bristol-Myers Squibb Business Overview
7.1.3 Bristol-Myers Squibb Immuno-Oncology Introduction
7.1.4 Bristol-Myers Squibb Revenue in Immuno-Oncology Business (2017-2022)
7.1.5 Bristol-Myers Squibb Recent Development
7.2 Merck & Co., Inc.
7.2.1 Merck & Co., Inc. Company Details
7.2.2 Merck & Co., Inc. Business Overview
7.2.3 Merck & Co., Inc. Immuno-Oncology Introduction
7.2.4 Merck & Co., Inc. Revenue in Immuno-Oncology Business (2017-2022)
7.2.5 Merck & Co., Inc. Recent Development
7.3 Roche AG
7.3.1 Roche AG Company Details
7.3.2 Roche AG Business Overview
7.3.3 Roche AG Immuno-Oncology Introduction
7.3.4 Roche AG Revenue in Immuno-Oncology Business (2017-2022)
7.3.5 Roche AG Recent Development
7.4 AstraZeneca, Plc
7.4.1 AstraZeneca, Plc Company Details
7.4.2 AstraZeneca, Plc Business Overview
7.4.3 AstraZeneca, Plc Immuno-Oncology Introduction
7.4.4 AstraZeneca, Plc Revenue in Immuno-Oncology Business (2017-2022)
7.4.5 AstraZeneca, Plc Recent Development
7.5 Sanofi S.A.
7.5.1 Sanofi S.A. Company Details
7.5.2 Sanofi S.A. Business Overview
7.5.3 Sanofi S.A. Immuno-Oncology Introduction
7.5.4 Sanofi S.A. Revenue in Immuno-Oncology Business (2017-2022)
7.5.5 Sanofi S.A. Recent Development
7.6 Dendreon Pharmaceuticals
7.6.1 Dendreon Pharmaceuticals Company Details
7.6.2 Dendreon Pharmaceuticals Business Overview
7.6.3 Dendreon Pharmaceuticals Immuno-Oncology Introduction
7.6.4 Dendreon Pharmaceuticals Revenue in Immuno-Oncology Business (2017-2022)
7.6.5 Dendreon Pharmaceuticals Recent Development
7.7.1 Novartis Company Details
7.7.2 Novartis Business Overview
7.7.3 Novartis Immuno-Oncology Introduction
7.7.4 Novartis Revenue in Immuno-Oncology Business (2017-2022)
7.7.5 Novartis Recent Development
7.8 Gilead Sciences Inc.
7.8.1 Gilead Sciences Inc. Company Details
7.8.2 Gilead Sciences Inc. Business Overview
7.8.3 Gilead Sciences Inc. Immuno-Oncology Introduction
7.8.4 Gilead Sciences Inc. Revenue in Immuno-Oncology Business (2017-2022)
7.8.5 Gilead Sciences Inc. Recent Development
7.9 Merck KGaA
7.9.1 Merck KGaA Company Details
7.9.2 Merck KGaA Business Overview
7.9.3 Merck KGaA Immuno-Oncology Introduction
7.9.4 Merck KGaA Revenue in Immuno-Oncology Business (2017-2022)
7.9.5 Merck KGaA Recent Development
For More Information About This Report, Please Enter:
Any doubts and questions will be welcome.
QYResearch founded in California, USA in 2007. It is a leading global market research and consulting company. With over 15 years’ experience and professional research team in various cities over the world, QY Research focuses on management consulting, database and seminar services, IPO consulting, industry chain research and customized research to help our clients in providing non-linear revenue model and make them successful. We are globally recognized for our expansive portfolio of services, good corporate citizenship, and our strong commitment to sustainability. Up to now, we have cooperated with more than 59,000 clients across five continents. Let’s work closely with you and build a bold and better future.
E-mail: [email protected]
Tel: +1-626-842-1666(US) +852-5808-0956 (HK)
Add: 17890 Castleton Street Suite 369 City of Industry CA 91748 United States